medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2012, Número 4

<< Anterior Siguiente >>

Ann Hepatol 2012; 11 (4)


Hepatotoxicity associated with dietary energy supplements: use and abuse by young athletes

Avelar-Escobar G, Méndez-Navarro J, Ortiz-Olvera NX, Castellanos G, Ramos R, Gallardo-Cabrera VE, Vargas-Alemán JJ, Díaz LÓ, Rodríguez EV, Dehesa-Violante M

Idioma: Ingles.
Referencias bibliográficas: 26
Paginas: 564-569
Archivo PDF: 259.21 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Stickel F, Kessebohm K, Weiman R, Seitz K. Review of liver injury associated with dietary supplements. Liver Int 2011; 31(5): 595-605.

  2. DesJardins M. Supplement use in the adolescent athlete. Current Sports Medicine Reports 2002; 1: 369-73.

  3. Favreau JT, Ryu ML, Braunstein G, et al. Severe hepatotoxicity associated with dietary supplement LipoKinetix. Ann Intern Med 2002; 136: 590-5.

  4. Di Luigi L. Supplements and the endocrine system in athletes. Clin Sports Med 2008; 27: 131-51.

  5. Hardy ML. Dietary supplement use in cancer care: Help or Harm. Hematol Oncol Clin N Am 2008; 22: 581-617.

  6. Stickel F, Droz S, Patsenker E, Bögli-Stuber K, Aebi B, Leib SL. Severe hepatotoxicity following ingestion of Herbalife nutritional supplements contaminated with Bacillus subtilis. J Hepatol 2009; 50: 111-7.

  7. García-Cortes M, Borraz Y, Lucena MI, et al. Liver injury induced by “natural remedies”: an analysis of cases submitted to the Spanish Liver Toxicity Registry. Rev Esp Enferm Dig 2008; 100: 688-95.

  8. Schoepfer AM, Engel A, Fattinger K, et al. Herbal does not mean innocuous: Ten cases of severe hepatotoxicity associated with dietary supplements from Herbalife products. J Hepatology 2007; 47: 521-6.

  9. Fong TL, Klontz K, Canas-Coto A, et al. Hepatotoxicity due to hydroxycut: A case series. Am J Gastroenterol 2010; 105: 1561-6.

  10. Sanchez W, Maple JT, Burgart LJ, Kamath PS. Severe hepatotoxicity associated with use of a dietary supplement containing usnic acid. Mayo Clin Proc 2006; 81: 541-4.

  11. Shah N, Zacharias I, Khettry U, Addhal N. Methasteron- Associatd Cholestatic Liver Injury: Clinicopathologic Findings in 5 cases. Clin Gastroenterol Hepatol 2008; 6: 255-8.

  12. Pugh AJ, Barve AJ, Falkener K, Patel M, McClain CJ. Drug- Induced hepatotoxicity or drug-induced liver injury. Clin Liver Dis 2009; 13: 277-94.

  13. Teschke R, Schwarzenboeck A, Hennermann KH. Causality assessment in hepatotoxicity by drugs and dietary supplements. Br J Clin Pharmacol 2008; 66: 758-66.

  14. Teschke R. Hepatotoxicity by drugs and dietary supplements: safety perspectives on clinical and regulatory issues. Ann Hepatol 2009; 8: 184-95.

  15. Scheuer PJ, Lefkowitch JH. Drugs and toxins. In: Liver Biopsy Intrepetation. 7th Ed. London UK: Elsevier & Saunders; 2006, p. 134-48.

  16. Zimmerman HJ, Ishak KG. Hepatic injury due to drugs and toxins. In: MacSween RNM, Burt AD, Portmann BC (eds.). Pathology of the liver. 4th Ed. Edinburg: Churchill Livingstone; 2002, p. 621.

  17. Aithal GP, Rawlins MD, Day CP. Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactions. J Hepatol 2000; 33: 949-52.

  18. Sleeper RB, Kennedy SM. Adverse reaction to a dietary supplement in an elderly patient. Ann Pharmacother 2003; 37: 83-6.

  19. Magee CD, Moawad FJ, Moses F. NO-Xplode: a case of supplement-associated ischemic colitis. Mil Med 2010; 175: 202-5.

  20. Prosser JM, Majlesi N, Chan GM, Olsen D, Hoffman RS, Nelson LS. Adverse effects associated with arginine a-ketoglutarate containing supplements. Hum Exp Toxicol 2009; 28: 259-62.

  21. Wang JS, Tan N, Dhawan A. Significance of low or normal serum gamma glutamyl transferase level in infants with idiopathic neonatal hepatitis. Eur J Pediatr 2006; 165: 795-801.

  22. Davit-Spraul A, Fabre M, Branchereau S, et al. ATP8B1 and ABCB11 analysis in 62 children with normal Gammaglutamyl transferase progressive Familial intrahepatic cholestasis (PFIC): Phenotypic differences between PFIC1 and PFIC2 and natural history. Hepatology 2010; 51: 1645-55.

  23. Diario Oficial de la Federación (DOF). Norma Oficial Mexicana NOM-251-SSA1-2009. Prácticas de higiene para el proceso de alimentos, bebidas o suplementos alimenticios. 1 de marzo de 2010. Disponible en: http:// www.dof.gob.mx/documentos/3980/salud/salud.htm [Retrieved: October 2011].

  24. Comisión Federal para la protección contra riesgos sanitarios (COFEPRIS). Productos milagro, su regulación comercial y publicitaria en México. Disponible en: http:// www.cofepris.gob.mx/work/sites/cfp/resources/Local- Content/402/1/b55.pdf [Retrieved: June 11, 2011].

  25. Cofepris ordena retiros de más de 250 productos “Milagro” por publicidad engañosa. 14 de febrero 2011. Disponible en: http://www.cofepris.gob.mx/Notas%20Principales/ 2011/Documentos/PM.pdf [Retrieved: June 11, 2011].

  26. Alerta Cofepris sobre el crecimiento de suplementos alimenticios para bajar supuestamente de peso. 26 de Agosto 2009. Disponible en: http://mymanuel.wordpress.com/ 2009/08/30/mexico-alerta-cofepris-sobre-el-crecimientode- suplementos-alimenticios-para-bajar-supuestamentede- peso/ [Retrieved: June 11, 2011].




2020     |     www.medigraphic.com